Potential drug interactions in cancer patients receiving supportive care exclusively.
about
The impact of comorbidity on cancer and its treatmentPotential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.Preventive medication use among persons with limited life expectancy.Polypharmacy in older adults with cancer.Senior adult oncology.Potential of Drug Interactions among Hospitalized Cancer Patients in a Developing Country.Drug interactions in oncology: how common are they?Prevalence of drug interactions in hospital healthcare.Enzyme induction with antiepileptic drugs: cause for concern?Inappropriate prescribing in patients accessing specialist palliative day care services.Analysis of drug interactions at the end of life.Drug interactions in cancer patients: A hidden risk?Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.Potential drug-drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study.Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia.Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center.Is there a role for neurologist in an oncological home care team?Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study.Evaluation of drug-drug interaction screening software combined with pharmacist intervention.Prevalence of potential drug-drug interactions in bone marrow transplant patients.Potential interactions with anticancer agents: a cross-sectional study.A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.Symptom Clusters and Quality of Life in Hospice Patients with CancerAge and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer.
P2860
Q26764935-441FF0F1-D8F4-4B08-ACD8-03ECABA64BA9Q34130767-E02D756F-CAAD-41D3-A769-46D3B188A5FDQ35023711-8BB6CBF4-3B4F-4132-B4F8-854F93575651Q35055271-3C5E5282-0A5F-423A-955D-445313F28395Q35584088-74D5D2E7-28EC-48CB-B9A7-ECE6EA95D707Q36851424-80B3E724-CB39-4A8B-80A6-486E660EAC7BQ37268706-0732D31D-A566-4FA0-9748-F29212F2A430Q37588305-BB80DF16-DA54-4264-88A3-F33A014AB756Q38042334-A086D5F6-B107-473D-AE33-A6C839CC9C11Q38046892-4C3A3E57-0E13-401B-8E17-FFEC8FB0162BQ38198553-2F8E8DDA-7409-4F17-94EE-EAE16AA4BBEDQ38427416-E40B0CE5-5B18-4BE0-BCE6-F5009DA93BBBQ40581891-5D01C98C-8FD1-4F95-954D-0DDE01AC0AE4Q41337668-D15A134C-F6DF-4C77-A85A-B76332519EB7Q41356935-5CA4EDB4-7FF9-4682-A766-AE2B1B0F9D8FQ42840345-358A0F35-89F2-4B7B-9821-5F29244089BFQ43485523-8FE151D5-BA48-4643-BE91-862DDAD4E927Q44557402-F80F85CA-EFA0-4E86-800E-49903EF41FC3Q44997486-41FE0B13-D25C-4804-AADB-A41090CC284EQ45176557-BA2B8196-78C5-4365-80FD-A08B0A7B0B38Q46096064-984AB2C8-103B-4EBB-8862-C5E6B1FFBD9DQ46177290-C73063D7-D067-4E5D-BD69-250B1DED5AA3Q46224729-B441232D-2A79-4752-919B-D55A649BD26BQ47106036-D7DE9F09-C224-4911-9DEA-F63225636643Q47124083-AA014ABB-0219-4D17-939A-B18C18199724Q50701246-D17082AE-AA4E-48D8-A18C-45B57CFB8515
P2860
Potential drug interactions in cancer patients receiving supportive care exclusively.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Potential drug interactions in cancer patients receiving supportive care exclusively.
@en
Potential drug interactions in cancer patients receiving supportive care exclusively.
@nl
type
label
Potential drug interactions in cancer patients receiving supportive care exclusively.
@en
Potential drug interactions in cancer patients receiving supportive care exclusively.
@nl
prefLabel
Potential drug interactions in cancer patients receiving supportive care exclusively.
@en
Potential drug interactions in cancer patients receiving supportive care exclusively.
@nl
P2093
P50
P1476
Potential drug interactions in cancer patients receiving supportive care exclusively
@en
P2093
Rachel P Riechelmann
Sanaz Zarinehbaf
Sheray N Chin
P304
P356
10.1016/J.JPAINSYMMAN.2007.06.009
P577
2008-02-04T00:00:00Z